• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

LyF-1,一种与一类新的淋巴细胞特异性基因启动子相互作用的转录调节因子。

LyF-1, a transcriptional regulator that interacts with a novel class of promoters for lymphocyte-specific genes.

作者信息

Lo K, Landau N R, Smale S T

机构信息

Howard Hughes Medical Institute, Molecular Biology Institute, UCLA School of Medicine 90024.

出版信息

Mol Cell Biol. 1991 Oct;11(10):5229-43. doi: 10.1128/mcb.11.10.5229-5243.1991.

DOI:10.1128/mcb.11.10.5229-5243.1991
PMID:1922043
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC361569/
Abstract

We have studied transcriptional control of the murine terminal deoxynucleotidyltransferase (TdT) gene, which is activated specifically in immature B and T lymphocytes. This analysis has led to the identification and purification of a 50-kDa sequence-specific DNA-binding protein, LyF-1, that interacts with the approximate consensus sequence PyPyTGGGAGPu and is enriched in cells at most stages of B- and T-cell differentiation. LyF-1 binds tightly to an element in the TdT promoter that we show is required for transcription in lymphocytes. LyF-1 also interacts with an element in the immunoglobulin mu enhancer, called microB, that was recently shown to be important for lymphocyte-specific enhancer activity. Moreover, LyF-1 binds to the promoters for the lymphocyte-specific genes lambda 5, VpreB, and lck, all of which we speculate have additional features in common with the TdT promoter. Thus, LyF-1 may be a general transcriptional activator for genes whose expression is restricted to the B- and/or T-lymphocyte lineages.

摘要

我们研究了小鼠末端脱氧核苷酸转移酶(TdT)基因的转录调控,该基因在未成熟的B淋巴细胞和T淋巴细胞中特异性激活。这项分析导致了一种50 kDa序列特异性DNA结合蛋白LyF-1的鉴定和纯化,该蛋白与近似共有序列PyPyTGGGAGPu相互作用,并在B细胞和T细胞分化的大多数阶段的细胞中富集。LyF-1紧密结合TdT启动子中的一个元件,我们证明该元件是淋巴细胞中转录所必需的。LyF-1还与免疫球蛋白μ增强子中的一个元件相互作用,该元件称为microB,最近被证明对淋巴细胞特异性增强子活性很重要。此外,LyF-1与淋巴细胞特异性基因lambda 5、VpreB和lck的启动子结合,我们推测所有这些基因与TdT启动子还有其他共同特征。因此,LyF-1可能是其表达仅限于B淋巴细胞和/或T淋巴细胞谱系的基因的一般转录激活因子。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f57/361569/c5484abea430/molcellb00034-0445-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f57/361569/94abbef3a7da/molcellb00034-0438-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f57/361569/f7433035ef6d/molcellb00034-0439-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f57/361569/dd41359abf95/molcellb00034-0440-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f57/361569/46d720c1b2d3/molcellb00034-0443-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f57/361569/8c512fd84df8/molcellb00034-0443-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f57/361569/4a50e81c0bda/molcellb00034-0444-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f57/361569/94eb1f8d673e/molcellb00034-0445-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f57/361569/c5484abea430/molcellb00034-0445-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f57/361569/94abbef3a7da/molcellb00034-0438-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f57/361569/f7433035ef6d/molcellb00034-0439-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f57/361569/dd41359abf95/molcellb00034-0440-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f57/361569/46d720c1b2d3/molcellb00034-0443-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f57/361569/8c512fd84df8/molcellb00034-0443-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f57/361569/4a50e81c0bda/molcellb00034-0444-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f57/361569/94eb1f8d673e/molcellb00034-0445-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f57/361569/c5484abea430/molcellb00034-0445-b.jpg

相似文献

1
LyF-1, a transcriptional regulator that interacts with a novel class of promoters for lymphocyte-specific genes.LyF-1,一种与一类新的淋巴细胞特异性基因启动子相互作用的转录调节因子。
Mol Cell Biol. 1991 Oct;11(10):5229-43. doi: 10.1128/mcb.11.10.5229-5243.1991.
2
The lymphoid transcription factor LyF-1 is encoded by specific, alternatively spliced mRNAs derived from the Ikaros gene.淋巴样转录因子LyF-1由源自Ikaros基因的特定可变剪接mRNA编码。
Mol Cell Biol. 1994 Nov;14(11):7111-23. doi: 10.1128/mcb.14.11.7111-7123.1994.
3
Both LyF-1 and an Ets protein interact with a critical promoter element in the murine terminal transferase gene.LyF-1和一种Ets蛋白都与小鼠末端转移酶基因中的一个关键启动子元件相互作用。
Mol Cell Biol. 1993 May;13(5):2982-92. doi: 10.1128/mcb.13.5.2982-2992.1993.
4
Regulation of lymphoid-specific immunoglobulin mu heavy chain gene enhancer by ETS-domain proteins.ETS 结构域蛋白对淋巴特异性免疫球蛋白 μ 重链基因增强子的调控
Science. 1993 Jul 2;261(5117):82-6. doi: 10.1126/science.8316859.
5
Identification of an octamer-binding site in the mouse kappa light-chain immunoglobulin enhancer.小鼠κ轻链免疫球蛋白增强子中八聚体结合位点的鉴定。
Mol Cell Biol. 1989 Oct;9(10):4239-47. doi: 10.1128/mcb.9.10.4239-4247.1989.
6
Isolation of a candidate repressor/activator, NF-E1 (YY-1, delta), that binds to the immunoglobulin kappa 3' enhancer and the immunoglobulin heavy-chain mu E1 site.分离出一种候选阻遏物/激活物NF-E1(YY-1,δ),它能与免疫球蛋白κ轻链3'增强子及免疫球蛋白重链μ E1位点结合。
Proc Natl Acad Sci U S A. 1991 Nov 1;88(21):9804-8. doi: 10.1073/pnas.88.21.9804.
7
Involvement of a second lymphoid-specific enhancer element in the regulation of immunoglobulin heavy-chain gene expression.第二个淋巴细胞特异性增强子元件参与免疫球蛋白重链基因表达的调控。
Mol Cell Biol. 1990 Jun;10(6):3155-62. doi: 10.1128/mcb.10.6.3155-3162.1990.
8
The intracisternal A-particle upstream element interacts with transcription factor YY1 to activate transcription: pleiotropic effects of YY1 on distinct DNA promoter elements.脑池内A颗粒上游元件与转录因子YY1相互作用以激活转录:YY1对不同DNA启动子元件的多效性作用。
Mol Cell Biol. 1993 Nov;13(11):6621-8. doi: 10.1128/mcb.13.11.6621-6628.1993.
9
Evolution of transcriptional control of the IgH locus: characterization, expression, and function of TF12/HEB homologs of the catfish.IgH基因座转录调控的进化:鲶鱼TF12/HEB同源物的表征、表达及功能
J Immunol. 2004 Nov 1;173(9):5476-84. doi: 10.4049/jimmunol.173.9.5476.
10
A nuclear factor that binds to a conserved sequence motif in transcriptional control elements of immunoglobulin genes.一种与免疫球蛋白基因转录控制元件中的保守序列基序结合的核因子。
Nature. 1986;319(6049):154-8. doi: 10.1038/319154a0.

引用本文的文献

1
PBK/TOPK mediates Ikaros, Aiolos and CTCF displacement from mitotic chromosomes and alters chromatin accessibility at selected C2H2-zinc finger protein binding sites.PBK/TOPK介导有丝分裂染色体上Ikaros、Aiolos和CTCF的移位,并改变特定C2H2-锌指蛋白结合位点处的染色质可及性。
Nat Commun. 2025 Sep 23;16(1):8348. doi: 10.1038/s41467-025-63740-4.
2
Insights into germline predisposition to pediatric lymphoid malignancies.对儿童淋巴系统恶性肿瘤种系易感性的见解。
Leukemia. 2025 Sep 9. doi: 10.1038/s41375-025-02750-z.
3
Critical roles of IKAROS and HDAC1 in regulation of heterochromatin and tumor suppression in T-cell acute lymphoblastic leukemia.

本文引用的文献

1
Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells.在哺乳动物细胞中表达氯霉素乙酰转移酶的重组基因组。
Mol Cell Biol. 1982 Sep;2(9):1044-51. doi: 10.1128/mcb.2.9.1044-1051.1982.
2
Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei.从分离的哺乳动物细胞核的可溶性提取物中,RNA聚合酶II进行准确的转录起始。
Nucleic Acids Res. 1983 Mar 11;11(5):1475-89. doi: 10.1093/nar/11.5.1475.
3
Identification of two distinct regulatory regions adjacent to the human beta-interferon gene.
IKAROS和HDAC1在T细胞急性淋巴细胞白血病中对异染色质调控及肿瘤抑制的关键作用
Leukemia. 2025 Jun 24. doi: 10.1038/s41375-025-02651-1.
4
Conserved helical motifs in the IKZF1 disordered region mediate NuRD interaction and transcriptional repression.IKZF1无序区域中保守的螺旋基序介导NuRD相互作用和转录抑制。
Blood. 2025 Jan 23;145(4):422-437. doi: 10.1182/blood.2024024787.
5
IKAROS Family Transcription Factors in Lymphocyte Differentiation and Function.IKAROS 家族转录因子在淋巴细胞分化和功能中的作用。
Adv Exp Med Biol. 2024;1459:33-52. doi: 10.1007/978-3-031-62731-6_2.
6
New precision medicine weapons for targeted treatment of high-risk B-cell precursor acute lymphoblastic leukemia.用于高危B细胞前体急性淋巴细胞白血病靶向治疗的新型精准医学武器。
Haematologica. 2024 Dec 1;109(12):3835-3837. doi: 10.3324/haematol.2024.285784.
7
A noncoding regulatory variant in IKZF1 increases acute lymphoblastic leukemia risk in Hispanic/Latino children.IKZF1 中的非编码调控变异增加了西班牙裔/拉丁裔儿童患急性淋巴细胞白血病的风险。
Cell Genom. 2024 Apr 10;4(4):100526. doi: 10.1016/j.xgen.2024.100526. Epub 2024 Mar 26.
8
IKAROS: from chromatin organization to transcriptional elongation control.IKAROS:从染色质组织到转录延伸控制
Cell Death Differ. 2025 Jan;32(1):37-55. doi: 10.1038/s41418-023-01212-2. Epub 2023 Aug 24.
9
The recombinase activating genes: architects of immune diversity during lymphocyte development.重组激活基因:淋巴细胞发育过程中免疫多样性的构建者。
Front Immunol. 2023 Jul 11;14:1210818. doi: 10.3389/fimmu.2023.1210818. eCollection 2023.
10
IKAROS in Acute Leukemia: A Positive Influencer or a Mean Hater?IKAROS 在急性白血病中的作用:正面影响者还是恶意攻击者?
Int J Mol Sci. 2023 Feb 7;24(4):3282. doi: 10.3390/ijms24043282.
鉴定出与人类β-干扰素基因相邻的两个不同调控区域。
Cell. 1983 Oct;34(3):865-79. doi: 10.1016/0092-8674(83)90544-5.
4
Transcriptional control signals of a eukaryotic protein-coding gene.真核生物蛋白质编码基因的转录控制信号
Science. 1982 Jul 23;217(4557):316-24. doi: 10.1126/science.6283634.
5
SV40-transformed simian cells support the replication of early SV40 mutants.猴空泡病毒 40(SV40)转化的猿猴细胞支持早期 SV40 突变体的复制。
Cell. 1981 Jan;23(1):175-82. doi: 10.1016/0092-8674(81)90282-8.
6
Sequencing end-labeled DNA with base-specific chemical cleavages.通过碱基特异性化学切割对末端标记的DNA进行测序。
Methods Enzymol. 1980;65(1):499-560. doi: 10.1016/s0076-6879(80)65059-9.
7
Cloning of terminal transferase cDNA by antibody screening.通过抗体筛选克隆末端转移酶cDNA。
Proc Natl Acad Sci U S A. 1984 Sep;81(18):5836-40. doi: 10.1073/pnas.81.18.5836.
8
Deoxynucleotide-polymerizing enzymes of calf thymus gland. II. Properties of the terminal deoxynucleotidyltransferase.小牛胸腺的脱氧核苷酸聚合酶。II. 末端脱氧核苷酸转移酶的性质。
J Biol Chem. 1967 Jun 10;242(11):2780-9.
9
Cytological evidence for a relationship between normal hemotopoietic colony-forming cells and cells of the lymphoid system.正常造血集落形成细胞与淋巴系统细胞之间关系的细胞学证据。
J Exp Med. 1968 Mar 1;127(3):455-64. doi: 10.1084/jem.127.3.455.
10
A new technique for the assay of infectivity of human adenovirus 5 DNA.一种检测人腺病毒5型DNA感染性的新技术。
Virology. 1973 Apr;52(2):456-67. doi: 10.1016/0042-6822(73)90341-3.